{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05980598",
            "orgStudyIdInfo": {
                "id": "ASND0038"
            },
            "organization": {
                "fullName": "Ascendis Pharma A/S",
                "class": "INDUSTRY"
            },
            "briefTitle": "TransCon (TC) TLR7/8 Agonist, TC IL-2 \u03b2/\u03b3, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma",
            "officialTitle": "BelieveIT-201: Phase 2, Randomized Open-labeled Trial of TransCon (TC) TLR7/8 Agonist in Combination With Pembrolizumab or With TC IL-2 \u03b2/\u03b3, or Pembrolizumab Alone as Neoadjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma",
            "acronym": "BelieveIT-201",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "transcon-tc-agonist-tc-il-pembrolizumab-prior-to-surgery-for-advanced-head-and-neck-squamous-cell-carcinoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-09-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-04-14",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-07-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-07-20",
            "studyFirstSubmitQcDate": "2023-08-04",
            "studyFirstPostDateStruct": {
                "date": "2023-08-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Ascendis Pharma Oncology Division A/S",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this trial is to evaluate the safety and efficacy of TransCon TLR7/8 Agonist, TransCon IL-2 \u03b2/\u03b3, and pembrolizumab given prior to curative intent surgery in treatment of participants with newly diagnosed Stage III/IVA resectable locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC). After surgery, participants will receive local standard-of-care treatment and will be followed for safety, efficacy, and survival for up to 2 years.\n\nThis trial contains a safety run-in to evaluate the safety and tolerability of the two treatment arms: Arm A (TransCon TLR7/8 Agonist plus pembrolizumab) and Arm B (TransCon TLR7/8 Agonist plus TransCon IL-2 \u03b2/\u03b3). The safety run-in will be followed by the randomized Phase 2, open-label part of the trial comparing the safety, efficacy and survival of treatment Arm A or Arm B compared to treatment Arm C (pembrolizumab monotherapy).",
            "detailedDescription": "This is a randomized, Phase 2, open-label, multicenter trial of TransCon TLR7/8 Agonist in combination with pembrolizumab, TransCon TLR7/8 Agonist in combination with TransCon IL-2 \u03b2/\u03b3, or pembrolizumab monotherapy as neoadjuvant therapy in participants with Stage III-IVA resectable LA-HNSCC.\n\nThis trial starts with a safety run-in of 12 participants, 6 participants each in Arms A (TransCon TLR7/8 Agonist plus pembrolizumab) and B (TransCon TLR7/8 Agonist plus TransCon IL-2 \u03b2/\u03b3) randomized 1:1.\n\nAfter completing the safety run-in, 80 participants will be randomized in a 2:2:1 ratio in 3 treatment Arms A, B or C (pembrolizumab monotherapy).\n\nOnce randomized, participants should begin treatment within 5 calendar days. Participants enrolled after the safety run-in, into the 2:2:1 randomization part of the trial, will be stratified as follows: oropharyngeal HPV p16 positive versus oropharyngeal HPV p16 negative or larynx/hypopharyngeal/oral cavity regardless of HPV p16 status. All participants should receive study drug(s) every 21 days (Q21D) for 2 cycles followed by curative-intent surgery. After surgery, participants may receive standard-of-care treatment in the adjuvant setting, as per investigator's decision and local guidelines."
        },
        "conditionsModule": {
            "conditions": [
                "Head and Neck Neoplasms"
            ],
            "keywords": [
                "HNSCC",
                "Head and Neck Cancer",
                "TransCon TLR7/8 Agonist",
                "TC TLR7/8",
                "TransCon IL-2 \u03b2/\u03b3",
                "TC IL-2 \u03b2/\u03b3",
                "Neoadjuvant",
                "Neoadjuvant Head and Neck",
                "LA-HNSCC",
                "Locoregionally Advanced HNSCC"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 92,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "TransCon TLR7/8 Agonist in combination with pembrolizumab",
                    "type": "EXPERIMENTAL",
                    "description": "Participants receive 2 cycles, once every 3 weeks of TransCon TLR7/8 Agonist intratumoral (IT) injection in combination with pembrolizumab as a 30-minute intravenous (IV) infusion",
                    "interventionNames": [
                        "Drug: TransCon TLR7/8 Agonist",
                        "Drug: Pembrolizumab"
                    ]
                },
                {
                    "label": "TransCon TLR7/8 Agonist in combination with TransCon IL-2 \u03b2/\u03b3",
                    "type": "EXPERIMENTAL",
                    "description": "Participants receive 2 cycles, once every 3 weeks of TransCon TLR7/8 Agonist (IT injection) in combination with TransCon IL-2 \u03b2/\u03b3 as a 30-minute IV infusion",
                    "interventionNames": [
                        "Drug: TransCon TLR7/8 Agonist",
                        "Drug: TransCon IL-2 \u03b2/\u03b3"
                    ]
                },
                {
                    "label": "Pembrolizumab",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants receive 2 cycles, once every 3 weeks of pembrolizumab alone as a 30-minute IV infusion",
                    "interventionNames": [
                        "Drug: Pembrolizumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "TransCon TLR7/8 Agonist",
                    "description": "TLR7/8 agonist prodrug",
                    "armGroupLabels": [
                        "TransCon TLR7/8 Agonist in combination with TransCon IL-2 \u03b2/\u03b3",
                        "TransCon TLR7/8 Agonist in combination with pembrolizumab"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Pembrolizumab",
                    "description": "A type of immunotherapy that works by blocking the PD-1 pathway to help prevent cancer cells from hiding",
                    "armGroupLabels": [
                        "Pembrolizumab",
                        "TransCon TLR7/8 Agonist in combination with pembrolizumab"
                    ],
                    "otherNames": [
                        "Keytruda\u2122"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "TransCon IL-2 \u03b2/\u03b3",
                    "description": "Sustained systemic release of IL-2 \u03b2/\u03b3 with selective receptor binding that may stimulate the immune system to kill cancer cells",
                    "armGroupLabels": [
                        "TransCon TLR7/8 Agonist in combination with TransCon IL-2 \u03b2/\u03b3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Major Pathological Response",
                    "description": "The proportion of participants with a major pathological response (mPR) as assessed by the Central Pathologist at the time of definitive surgery. mPR is defined as \u226410% invasive squamous cell carcinoma within the resected primary tumor specimen and all the sampled regional lymph nodes.",
                    "timeFrame": "Up to 6 weeks after Cycle 2 (each cycle is 21 days)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Pathological Complete Response",
                    "description": "A central pathology laboratory and local hospital pathologist will evaluate if all the tumor is completely gone from the primary tumor and all the lymph nodes that were removed at surgery.",
                    "timeFrame": "Up to 6 weeks after Cycle 2 (each cycle is 21 days)"
                },
                {
                    "measure": "Event Free Survival",
                    "description": "The time from the date of randomization to the date of first record of any of the following events: disease progression; local or distant recurrence determined by radiology scans or tumor biopsy as needed, or death due to any cause.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Overall Survival",
                    "description": "The time from randomization to death due to any cause.",
                    "timeFrame": "Up to 5 years"
                },
                {
                    "measure": "Safety and Tolerability",
                    "description": "Incidence and severity of adverse events (AEs) and serious adverse events (SAEs).",
                    "timeFrame": "From time of signing of the ICF up to 100 (\u00b17) days following the last dose of study drug"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Has local histologically confirmed new diagnosis of resectable, non-metastatic, SCC that is either: Stage III tumor HPV-positive oropharyngeal primary that is tumor size (T) 4, lymph node involvement (N) 0-2, no distant metastases (M) 0; Stage III or IVA oropharyngeal tumor HPV-negative; or Stage III or IVA larynx/hypopharynx/oral cavity primaries regardless of HPV status (per American Joint Committee on Cancer \\[AJCC\\] Staging, 8th edition).\n* Has available archived or fresh core or excisional biopsy of a tumor lesion. Note: Fine needle aspirations may be allowed after discussion with Medical Monitor.\n* Is eligible and plans for primary LA-HNSCC surgery based on investigator decision and per local practice.\n* Has results from tumor HPV status by p16 immunohistochemistry (IHC) for oropharyngeal tumors. (HPV DNA analysis for HPV tumor status is acceptable if that is the local standard of care analysis.)\n* Has adequate organ function at screening.\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.\n* Has at least one lesion that is deemed by the investigator to be easily and safely accessible for IT injection.\n\nExclusion Criteria:\n\n* Active autoimmune conditions.\n* Has significant cardiac disease.\n* Has a known bleeding disorder that is deemed to place the participant at unacceptable risk for bleeding complications from IT injections or biopsies.\n* Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy (in doses exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to randomization.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ascendis Oncology Clinical Trials",
                    "role": "CONTACT",
                    "phone": "+1 650 352 8389",
                    "email": "OncologyClinicalTrials@ascendispharma.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Joan Morris",
                    "affiliation": "Ascendis Pharma Oncology Division A/S",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90067",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94158",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Louisville",
                    "state": "Kentucky",
                    "zip": "40202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.25424,
                        "lon": -85.75941
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48201",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "11794",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Ascendis Pharma Investigational Site",
                    "status": "RECRUITING",
                    "city": "Canton",
                    "state": "Ohio",
                    "zip": "44718",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.79895,
                        "lon": -81.37845
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45219",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Knoxville",
                    "state": "Tennessee",
                    "zip": "37902",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.96064,
                        "lon": -83.92074
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Kutaisi",
                    "state": "Imereti",
                    "zip": "4600",
                    "country": "Georgia",
                    "geoPoint": {
                        "lat": 42.26791,
                        "lon": 42.69459
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Tbilisi",
                    "zip": "0114",
                    "country": "Georgia",
                    "geoPoint": {
                        "lat": 41.69411,
                        "lon": 44.83368
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Tbilisi",
                    "zip": "0144",
                    "country": "Georgia",
                    "geoPoint": {
                        "lat": 41.69411,
                        "lon": 44.83368
                    }
                },
                {
                    "facility": "Ascendis Investigational Site II",
                    "status": "RECRUITING",
                    "city": "Tbilisi",
                    "zip": "0159",
                    "country": "Georgia",
                    "geoPoint": {
                        "lat": 41.69411,
                        "lon": 44.83368
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Tbilisi",
                    "zip": "0159",
                    "country": "Georgia",
                    "geoPoint": {
                        "lat": 41.69411,
                        "lon": 44.83368
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Tbilisi",
                    "zip": "0186",
                    "country": "Georgia",
                    "geoPoint": {
                        "lat": 41.69411,
                        "lon": 44.83368
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Erlangen",
                    "state": "Bavaria",
                    "zip": "91054",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.59099,
                        "lon": 11.00783
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Mannheim",
                    "zip": "68167",
                    "country": "Germany",
                    "geoPoint": {
                        "lat": 49.4891,
                        "lon": 8.46694
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "P\u00e9cs",
                    "state": "Baranya",
                    "zip": "7624",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 46.08333,
                        "lon": 18.23333
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Budapest",
                    "zip": "1122",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.49801,
                        "lon": 19.03991
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Debrecen",
                    "zip": "4032",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.53333,
                        "lon": 21.63333
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Gy\u0151r",
                    "zip": "9024",
                    "country": "Hungary",
                    "geoPoint": {
                        "lat": 47.68333,
                        "lon": 17.63512
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Meldola",
                    "zip": "47014",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 44.12775,
                        "lon": 12.0626
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Milan",
                    "zip": "20133",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Naples",
                    "zip": "80131",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 40.85216,
                        "lon": 14.26811
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Novara",
                    "zip": "28100",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.44694,
                        "lon": 8.62118
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Rozzano",
                    "zip": "20089",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.38193,
                        "lon": 9.1559
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Warszawa",
                    "zip": "02-781",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 52.22977,
                        "lon": 21.01178
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08003",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "El Palmar",
                    "zip": "30120",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.93939,
                        "lon": -1.16095
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "L'Hospitalet De Llobregat",
                    "zip": "08908",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.35967,
                        "lon": 2.10028
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28027",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Ascendis Investigational Site II",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28050",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "M\u00e1laga",
                    "zip": "29011",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 36.72016,
                        "lon": -4.42034
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Pamplona",
                    "zip": "31008",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 42.81687,
                        "lon": -1.64323
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Terrassa",
                    "zip": "08221",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.56667,
                        "lon": 2.01667
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46009",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46014",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Valencia",
                    "zip": "46026",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Zaragoza",
                    "zip": "50009",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.65606,
                        "lon": -0.87734
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Kaohsiung City",
                    "zip": "80708",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.61626,
                        "lon": 120.31333
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Tainan",
                    "zip": "70456",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 22.99083,
                        "lon": 120.21333
                    }
                },
                {
                    "facility": "Ascendis Investigational Site",
                    "status": "RECRUITING",
                    "city": "Taoyuan",
                    "zip": "333",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 24.95233,
                        "lon": 121.20193
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002294",
                    "term": "Carcinoma, Squamous Cell"
                },
                {
                    "id": "D000077195",
                    "term": "Squamous Cell Carcinoma of Head and Neck"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000018307",
                    "term": "Neoplasms, Squamous Cell"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5550",
                    "name": "Carcinoma, Squamous Cell",
                    "asFound": "Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "asFound": "Head and Neck Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1689",
                    "name": "Squamous Cell Carcinoma of Head and Neck",
                    "asFound": "Head and Neck Squamous Cell Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M20451",
                    "name": "Neoplasms, Squamous Cell",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2853",
                    "name": "Immunomodulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}